312 related articles for article (PubMed ID: 33009111)
1. A Potential Antiviral Treatment for COVID-19: Remdesivir.
O'Malley PA
Clin Nurse Spec; 2020; 34(6):257-260. PubMed ID: 33009111
[No Abstract] [Full Text] [Related]
2. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
[No Abstract] [Full Text] [Related]
3. Remdesivir: a pendulum in a pandemic.
Schwartz IS; Heil EL; McCreary EK
BMJ; 2020 Nov; 371():m4560. PubMed ID: 33234523
[No Abstract] [Full Text] [Related]
4. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
Chua KP; Conti RM
JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187
[No Abstract] [Full Text] [Related]
5. Assessing the evidence on remdesivir.
Trøseid M; Hites M; Barratt-Due A; Ader F; Yazdanpanah Y
Lancet Infect Dis; 2021 Dec; 21(12):1630-1631. PubMed ID: 34838222
[No Abstract] [Full Text] [Related]
6. Remdesivir (Veklury) for COVID-19.
Med Lett Drugs Ther; 2020 Nov; 62(1612):186-188. PubMed ID: 33443491
[No Abstract] [Full Text] [Related]
7. [Remdesivir for patients with severe COVID-19].
Augustin M; Hallek M; Nitschmann S
Internist (Berl); 2020 Jun; 61(6):644-645. PubMed ID: 32333086
[No Abstract] [Full Text] [Related]
8. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
Ison MG; Wolfe C; Boucher HW
JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
[No Abstract] [Full Text] [Related]
9. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
Thalha AMM; Lee YY; Besari A; Omar SFS
J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
[No Abstract] [Full Text] [Related]
10. Audio Interview: New Data on Remdesivir in Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
[No Abstract] [Full Text] [Related]
11. Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement.
Paladugu S; Donato AA
Ann Intern Med; 2020 Jul; 173(2):JC4. PubMed ID: 32687756
[TBL] [Abstract][Full Text] [Related]
12. Rapid review for the anti-coronavirus effect of remdesivir.
Li Z; Wang X; Cao D; Sun R; Li C; Li G
Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648
[TBL] [Abstract][Full Text] [Related]
13. Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019.
Igbinosa I; Miller S; Bianco K; Nelson J; Kappagoda S; Blackburn BG; Grant P; Subramanian A; Lyell DJ; El-Sayed YY; Aziz N
Am J Obstet Gynecol; 2020 Nov; 223(5):768-770. PubMed ID: 32771381
[No Abstract] [Full Text] [Related]
14. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898
[No Abstract] [Full Text] [Related]
15. FDA Approval of Remdesivir - A Step in the Right Direction.
Rubin D; Chan-Tack K; Farley J; Sherwat A
N Engl J Med; 2020 Dec; 383(27):2598-2600. PubMed ID: 33264539
[No Abstract] [Full Text] [Related]
16. Missed Opportunities on Emergency Remdesivir Use.
Sarpatwari A; Kaltenboeck A; Kesselheim AS
JAMA; 2020 Jul; 324(4):331-332. PubMed ID: 32579163
[No Abstract] [Full Text] [Related]
17. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
18. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
[No Abstract] [Full Text] [Related]
19. Commentary: "Emergency Use Authorization for Remdesivir: A Pediatric Perspective".
Noel GJ; Connor E
Pediatr Infect Dis J; 2020 Sep; 39(9):e234. PubMed ID: 32639464
[No Abstract] [Full Text] [Related]
20. Remdesivir Approved to Treat COVID-19 Amid Controversy.
Aschenbrenner DS
Am J Nurs; 2021 Jan; 121(1):22-24. PubMed ID: 33350691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
